malondialdehyde has been researched along with ginkgetin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bian, H; Dou, QL; Huang, XW; Li, N; Liu, WH; Liu, X; Tao, WY; Zhang, WW | 1 |
Erjiong, H; Jian, P; Qihan, Z; Wei, L | 1 |
2 other study(ies) available for malondialdehyde and ginkgetin
Article | Year |
---|---|
Ginkgetin Alleviates Inflammation, Oxidative Stress, and Apoptosis Induced by Hypoxia/Reoxygenation in H9C2 Cells via Caspase-3 Dependent Pathway.
Topics: Animals; Apoptosis; Biflavonoids; Caspase 3; Cell Hypoxia; Cell Line; Cytokines; Malondialdehyde; Myocardial Reperfusion Injury; Myocarditis; Myocytes, Cardiac; Oxidative Stress; Oxygen; Rats; Reactive Oxygen Species | 2020 |
Ginkgetin alleviates high glucose-evoked mesangial cell oxidative stress injury, inflammation, and extracellular matrix (ECM) deposition in an AMPK/mTOR-mediated autophagy axis.
Topics: AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Antioxidants; Autophagy; Biflavonoids; Collagen; Diabetic Nephropathies; Extracellular Matrix; Fibronectins; Glucose; Humans; Inflammation; Malondialdehyde; Mesangial Cells; Oxidative Stress; Signal Transduction; Superoxide Dismutase; TOR Serine-Threonine Kinases | 2021 |